Exeter Collaboration for Academic Primary Care (APEx) Blog
Exeter Collaboration for Academic Primary Care (APEx) Blog
There’s nothing quite like a conference held at a Cypriot beachfront hotel to put a spring in a researcher’s step. Beyond the glass doors of the conference venue, palm trees framed a bright Mediterranean sea, and the September sun made the sandy shoreline particularly tempting. Inside, poster boards, coffee cups and lively conversations filled the […]
Earlier this month I had the opportunity to travel to Stuttgart for the European Forum for Primary Care (EFPC) 2026 conference, where I presented two areas of our research; the development of the GP PA Toolkit and our evaluation of the parkrun practice initiative. Both projects explore, in different ways, how primary care might support […]
Professor David MG Halpin Honorary Professor of Respiratory Medicine Approximately 40,000 patients in England are on long term oxygen therapy (LTOT) in the community. Most of them have chronic obstructive pulmonary disease (COPD) but some have other lung diseases such as cystic fibrosis or bronchiectasis, and some have chronic heart failure. They are prescribed oxygen […]
Dr Jo Butterworth previously shared news of securing aTeam Science Award | NIHR to support the Multiple Long-Term Conditions Cross-NIHR Collaboration | NIHR, bringing together an interdisciplinary team from across the UK to address important unanswered questions about care for people living with multiple long-term conditions (MLTC). The workstream (involving researchers, clinicians, methodologists, public contributors […]
What is Atrial Fibrillation and why does it matter? Atrial fibrillation (AF) is a common heart condition. It increases risk of developing other conditions, like heart failure, or having a stroke and dying early. For many people, AF can be frightening and confusing. People with AF often describe a constant daily balancing act between making […]
Caring for people with long-term conditions takes up substantial resources. This isn’t news, but it’s surprising how much we still don’t know. It’s often simple stuff, that would really help us deliver care more effectively and efficiently. Work being undertaken by APEx academics in our Long-Term Conditions research theme is looking at some of these […]
A few members of the team following the IMPPP dissemination event at RCGP in October 2025 The research process can be a long one. Back in 2016, NIHRput a call out for evidence for interventions to improve the management ofpolypharmacy. By early in 2018, we had been awarded just under £2 million byHSDR to develop, […]
Patient and public involvement (PPI) in research is about researchers and patients/public members working together in equal partnership to do research. PPI in health research is critical because it ensures that the research we do is relevant to and benefits those most impacted by the research. PPI for large programmes of work involving multiple studies […]
I was recently moaning about the fact that a colleague of mine is presenting the economic evaluation of our recent IMPPP clinical trial at the International Health Economics Association congress later this month. In Bali. Meanwhile, yours truly had to make do with a trip to Cardiff for this year’s SAPC Annual Scientific Meeting. Clearly […]
When Prof Rupert Payne and I got our heads together to start writing our latest BJGP Editorial GLP-1 receptor agonists: panacea or affirmation of societal failure? It was difficult to know where to start. GLP-1 receptor agonists under the various brand names of Ozempic, Wegovy and Mounjaro have sky rocketed in use over recent years. […]